首页> 外国专利> Prognosis prediction method and / or pharmacological response in neuroblastoma.

Prognosis prediction method and / or pharmacological response in neuroblastoma.

机译:神经母细胞瘤的预后预测方法和/或药理反应。

摘要

Prognosis prediction method and / or pharmacological response in neuroblastoma. # The present invention relates to the use of expression levels of CHD5, PAFAH1B1 and NME1 genes as prognostic marker and / or pharmacological response in patients with neuroblastoma. Also it refers to the method of prognosis and / or pharmacological response of a patient with NB based on the quantification of the expression of these genes, as well as the kit to carry out.
机译:神经母细胞瘤的预后预测方法和/或药理反应。本发明涉及CHD5,PAFAH1B1和NME1基因表达水平在神经母细胞瘤患者中作为预后标志和/或药理反应的用途。还涉及基于这些基因表达的定量的NB患者的预后和/或药理反应的方法,以及要进行的试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号